Edwards Lifesciences Corporation
EW
Clasificación en acciones
#477
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Precio por acción
$88.02
Capitalización bursátil
$50.73B
Cambio (1 día)
0.84%
Cambio (1 año)
16.91%
País
US
Comercio Edwards Lifesciences Corporation (EW)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Edwards Lifesciences Corporation (EW)
La acción Edwards Lifesciences Corporation (símbolo: EW) tuvo un total de 3 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jun 01, 2020.
Una acción EW comprada antes de May 28, 2010 equivaldría hoy a 12 acciones EW.
El desdoblamiento más reciente ocurrió el Jun 01, 2020.
Una acción EW comprada antes de May 28, 2010 equivaldría hoy a 12 acciones EW.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2020-06-01 | 3:1 | x3 | x12 |
| 2015-12-14 | 2:1 | x2 | x4 |
| 2010-05-28 | 2:1 | x2 | x2 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
